The Effects of Cannabis Among Adults With Chronic Pain and an Overview of General Harms A Systematic Review

被引:221
作者
Nugent, Shannon M. [1 ]
Morasco, Benjamin J. [2 ]
O'Neil, Maya E. [1 ]
Freeman, Michele [3 ]
Low, Allison [3 ]
Kondo, Karli [3 ]
Elven, Camille [4 ]
Zakher, Bernadette [5 ]
Motu'apuaka, Makalapua [3 ]
Paynter, Robin [3 ]
Kansagara, Devan [3 ]
机构
[1] VA Portland Hlth Care Syst, Mail Code R&D66,3710 SW US Vet Hosp Rd, Portland, OR 97239 USA
[2] VA Portland Hlth Care Syst, Mail Code R&D99,3710 SW US Vet Hosp Rd, Portland, OR 97239 USA
[3] VA Portland Hlth Care Syst, Mail Code R&D71,3710 SW US Vet Hosp Rd, Portland, OR 97239 USA
[4] VA Portland Hlth Care Syst, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA
[5] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA
关键词
CENTRAL NEUROPATHIC PAIN; MARIJUANA USE; DOUBLE-BLIND; MULTIPLE-SCLEROSIS; PULMONARY ASPERGILLOSIS; HYPEREMESIS SYNDROME; MEDICINAL EXTRACTS; MEDICAL CANNABIS; SUBSTANCE USE; VAPORIZED CANNABIS;
D O I
10.7326/M17-0155
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cannabis is increasingly available for the treatment of chronic pain, yet its efficacy remains uncertain. Purpose: To review the benefits of plant-based cannabis preparations for treating chronic pain in adults and the harms of cannabis use in chronic pain and general adult populations. Data Sources: MEDLINE, Cochrane Database of Systematic Reviews, and several other sources from database inception to March 2017. Study Selection: Intervention trials and observational studies, published in English, involving adults using plant-based cannabis preparations that reported pain, quality of life, or adverse effect outcomes. Data Extraction: Two investigators independently abstracted study characteristics and assessed study quality, and the investigator group graded the overall strength of evidence using standard criteria. Data Synthesis: From 27 chronic pain trials, there is low-strength evidence that cannabis alleviates neuropathic pain but insufficient evidence in other pain populations. According to 11 systematic reviews and 32 primary studies, harms in general population studies include increased risk for motor vehicle accidents, psychotic symptoms, and short-term cognitive impairment. Although adverse pulmonary effects were not seen in younger populations, evidence on most other long-term physical harms, in heavy or long-term cannabis users, or in older populations is insufficient. Limitation: Few methodologically rigorous trials; the cannabis formulations studied may not reflect commercially available products; and limited applicability to older, chronically ill populations and patients who use cannabis heavily. Conclusion: Limited evidence suggests that cannabis may alleviate neuropathic pain in some patients, but insufficient evidence exists for other types of chronic pain. Among general populations, limited evidence suggests that cannabis is associated with an increased risk for adverse mental health effects.
引用
收藏
页码:319 / +
页数:14
相关论文
共 100 条
[61]   Sativex successfully treats neuropathic pain characterised by allodynia: A randomised, double-blind, placebo-controlled clinical trial [J].
Nurmikko, Turo J. ;
Serpell, Mick G. ;
Hoggart, Barbara ;
Toomey, Peter J. ;
Morlion, Bart J. ;
Haines, Derek .
PAIN, 2007, 133 (1-3) :210-220
[62]   Tuberculosis outbreak in marijuana users, Seattle, Washington, 2004 [J].
Oeltmann, John E. ;
Oren, Eyal ;
Haddad, Maryam B. ;
Lake, Linda K. ;
Harrington, Theresa A. ;
Ijaz, Kashef ;
Narita, Masahiro .
EMERGING INFECTIOUS DISEASES, 2006, 12 (07) :1156-1159
[63]   Association Between Marijuana Exposure and Pulmonary Function Over 20 Years [J].
Pletcher, Mark J. ;
Vittinghoff, Eric ;
Kalhan, Ravi ;
Richman, Joshua ;
Safford, Monika ;
Sidney, Stephen ;
Lin, Feng ;
Kertesz, Stefan .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (02) :173-181
[64]   Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial [J].
Portenoy, Russell K. ;
Ganae-Motan, Elena Doina ;
Allende, Silvia ;
Yanagihara, Ronald ;
Shaiova, Lauren ;
Weinstein, Sharon ;
McQuade, Robert ;
Wright, Stephen ;
Fallon, Marie T. .
JOURNAL OF PAIN, 2012, 13 (05) :438-449
[65]  
Ramos S, 2013, PSYCHOTHER PSYCHOSOM, V82, P90
[66]   The Prevalence and Significance of Cannabis Use in Patients Prescribed Chronic Opioid Therapy: A Review of the Extant Literature [J].
Reisfield, Gary M. ;
Wasan, Ajay D. ;
Jamison, Robert N. .
PAIN MEDICINE, 2009, 10 (08) :1434-1441
[67]   Linking substance use with symptoms of subclinical psychosis in a community cohort over 30 years [J].
Roessler, Wulf ;
Hengartner, Michael P. ;
Angst, Jules ;
Ajdacic-Gross, Vladeta .
ADDICTION, 2012, 107 (06) :1174-1184
[68]   Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis [J].
Rog, DJ ;
Nurmikko, TJ ;
Friede, T ;
Young, CA .
NEUROLOGY, 2005, 65 (06) :812-819
[69]   The effects of cannabis intoxication on motor vehicle collision revisited and revised [J].
Rogeberg, Ole ;
Elvik, Rune .
ADDICTION, 2016, 111 (08) :1348-1359
[70]   Prevalence of medical marijuana use in California, 2012 [J].
Ryan-Ibarra, Suzanne ;
Induni, Marta ;
Ewing, Danielle .
DRUG AND ALCOHOL REVIEW, 2015, 34 (02) :141-146